Mohsen, Mona O.
Rothen, Dominik
Balke, Ina https://orcid.org/0000-0002-5171-7744
Martina, Byron
Zeltina, Vilija
Inchakalody, Varghese
Gharailoo, Zahra
Nasrallah, Gheyath https://orcid.org/0000-0001-9252-1038
Dermime, Said https://orcid.org/0000-0002-5526-7496
Tars, Kaspars
Vogel, Monique
Zeltins, Andris
Bachmann, Martin F. https://orcid.org/0000-0003-4370-2099
Funding for this research was provided by:
Qatar National Research Fund (PDRA4-0118-18002)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_185114)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Hamad Medical Corporation (grant 29032016)
Article History
Received: 22 February 2021
Accepted: 16 July 2021
First Online: 24 August 2021
Competing interests
: M. F. Bachmann is a board member of Saiba AG, holds the patent of CuMV<sub>TT</sub>-VLPs.